demonstrated that GABPA can activate telomerase/TERT in bladder cancer and drive luminal differentiation of urinary tract epithelial cells by directly activating transcription of FOXA1 and GATA3, thereby inhibiting the aggressiveness of tumor cells and playing a tumor-suppressive role.27 The gene discussed is TERT; the disease is urinary bladder carcinoma.